Medicare Enrolled

Dr. Dominic Hovsepian, MD

Epilepsy Physician · Palo Alto, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
795 EL CAMINO REAL, Palo Alto, CA 94022
6508534765
In practice since 2014 (12 years)
NPI: 1154749588 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hovsepian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hovsepian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hovsepian

Dr. Dominic Hovsepian is an epilepsy physician in Palo Alto, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Hovsepian performed 1,037 Medicare services across 866 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hovsepian received a total of $31,415 from 60 pharmaceutical and/or device companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hovsepian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 19% volume in CA $31,415 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,037
Medicare services
Top 19% in CA for epilepsy physician
866
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
401 $107 $460
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
164 $55 $315
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $76 $325
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
94 $149 $585
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
49 $155 $722
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
39 $63 $415
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
31 $120 $602
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
27 $43 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
27 $154 $635
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
25 $97 $438
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
23 $85 $306
New patient office visit, complex (60-74 min) 16 $168 $770
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$31,415
Total received (2020-2024)
Avg $6,283/year across 5 years
Top 17% in CA for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
587
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,140 (64.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,276 (35.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,111
2023
$2,452
2022
$12,415
2021
$9,518
2020
$5,919

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$237
Eisai Inc.
$125
Neurocrine Biosciences, Inc.
$109
UCB, Inc.
$96
Novartis Pharmaceuticals Corporation
$73
BANNER LIFE SCIENCES, LLC
$64
Teva Pharmaceuticals USA, Inc.
$49
Biogen, Inc.
$49
Neurelis, Inc.
$47
Acorda Therapeutics, Inc
$45
Kyowa Kirin, Inc.
$34
Lundbeck LLC
$32
Sumitomo Pharma America, Inc.
$24
MDD US Operations, LLC
$24
PFIZER INC.
$23
Amgen Inc.
$23
Amneal Pharmaceuticals LLC
$22
SK Life Science, Inc.
$22
Averitas Pharma Inc.
$15
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2020-2024) ›
SK Life Science, Inc.
$20,297
Teva Pharmaceuticals USA, Inc.
$1,417
UCB, Inc.
$826
ABBVIE INC.
$720
Neurocrine Biosciences, Inc.
$646
JAZZ PHARMACEUTICALS INC.
$497
Celgene Corporation
$450
Biogen, Inc.
$444
Alexion Pharmaceuticals, Inc.
$407
Avanir Pharmaceuticals, Inc.
$391
Lilly USA, LLC
$366
Biohaven Pharmaceuticals, Inc.
$355
Sunovion Pharmaceuticals Inc.
$319
Greenwich Biosciences, Inc.
$273
Sumitomo Pharma America, Inc.
$257
Janssen Pharmaceuticals, Inc
$251
AbbVie Inc.
$234
Acorda Therapeutics, Inc
$228
Biohaven Pharmaceutical Holding Company Ltd.
$212
Neurelis, Inc.
$183
IMPEL PHARMACEUTICALS INC.
$157
Amgen Inc.
$148
Lundbeck LLC
$145
Mallinckrodt Hospital Products Inc.
$132
Eisai Inc.
$125
Adamas Pharmaceuticals, Inc.
$124
GRT US Holding, Inc.
$122
Horizon Therapeutics plc
$101
Allergan, Inc.
$96
Ironshore Pharmaceuticals Inc.
$91
Supernus Pharmaceuticals, Inc.
$91
BANNER LIFE SCIENCES, LLC
$91
PFIZER INC.
$90
Kyowa Kirin, Inc.
$84
ACADIA Pharmaceuticals Inc
$82
Banner Life Sciences, LLC
$77
Amneal Pharmaceuticals LLC
$73
Novartis Pharmaceuticals Corporation
$73
MDD US Operations, LLC
$72
GE HealthCare
$65
UPSHER-SMITH LABORATORIES LLC
$57
ARGENX US, INC.
$48
BOSTON SCIENTIFIC CORPORATION
$45
Averitas Pharma Inc.
$45
Genentech USA, Inc.
$44
Exeltis, USA Inc.
$44
Avion Pharmaceuticals
$37
Medtronic, Inc.
$33
US WorldMeds, LLC
$29
NEUROPACE, INC.
$26
Boston Scientific Corporation
$26
Nevro Corp.
$24
Otsuka America Pharmaceutical, Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$22
Ultragenyx Pharmaceutical Inc.
$20
GE HEALTHCARE
$19
Merz Pharmaceuticals, LLC
$18
Xeris Pharmaceuticals, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 71.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AJOVY · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · Briviact · COMIRNATY · Cenobamate · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · GOCOVRI · General - DBS · Gocovri · Horizant · INBRIJA · INGREZZA · JORNAY PM · KESIMPTA · KEVEYIS · KYNMOBI · LONHALA MAGNAIR · Leqembi · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PAXLOVID · PURIFIED CORTROPHIN GEL · Percept · Ponvory · QELBREE · QULIPTA · QUTENZA · Qutenza · REXULTI · RNS Neurostimulator Kit · RYTARY · Rystiggo · SOLIRIS · Soliris · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UNITHROID · UPLIZNA · VALTOCO · VERCISE · VRAYLAR · VYEPTI · VYVGART · XCOPRI · Xadago · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in epilepsy physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for an epilepsy physician in Palo Alto?
Compare epilepsy physicians in the Palo Alto area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians within 10 mi
15
Per 100K population
0.8
County median income
$159,674
Nearest hospital
PALO ALTO VA MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hovsepian is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with speaking/promotional industry engagement in the top 17% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hovsepian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hovsepian performed 401 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hovsepian receive payments from pharmaceutical companies?
Yes. Dr. Hovsepian received a total of $31,415 from 60 companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hovsepian's costs compare to other epilepsy physicians in Palo Alto?
Dr. Hovsepian's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hovsepian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →